INVO Bioscience, Inc.
Industry
- Medical Devices
- Services
Other Names/Subsidiaries
- Emy’s Salsa Aji Distribution Company, Inc.
Latest on INVO Bioscience, Inc.
In the fourth quarter of 2023, Casgevy (exagamglogene autotemcel) – a CRISPR-based therapeutic developed by Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG – was approved by the US
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With Verve Again By Acqu
Collaborations for advanced diagnostics, including the application of artificial intelligence to track structural heart disease, lead the list of collaborations announced by the medical device industr
Having acquired Rebiotix Inc. in 2018 to advance its research into the human microbiome, Ferring Pharmaceuticals AS has unveiled a large clinical program involving 9,000 people to investigate its